{{Rsnum
|rsid=11240594
|Gene=SLC26A9
|Chromosome=1
|position=205927107
|Orientation=plus
|GMAF=0.2888
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC26A9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 33.6 | 63.7
| HCB | 30.7 | 51.1 | 18.2
| JPT | 29.2 | 54.0 | 16.8
| YRI | 2.0 | 28.6 | 69.4
| ASW | 12.5 | 32.1 | 55.4
| CHB | 30.7 | 51.1 | 18.2
| CHD | 38.5 | 42.2 | 19.3
| GIH | 4.0 | 28.7 | 67.3
| LWK | 8.2 | 36.4 | 55.5
| MEX | 6.9 | 27.6 | 65.5
| MKK | 9.0 | 36.5 | 54.5
| TSI | 3.9 | 28.4 | 67.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=1E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}